Two vitamin C manufacturers based in China are reportedly arguing in a New York court that their government is responsible for their price-fixing. A class-action suit has been filed in US District Court in New York accusing two vitamin C companies of raising prices between December 2001 and June 2006. The media are reporting that the defendants will use the foreign sovereign compulsion doctrine defense, a rare argument that claims companies that break US law are protected if their own governments coerced the companies into that legal violation. The defense is seldom successful, say experts. Jury selection was scheduled for Monday.
Featured News
Dozens of State AGs Demand AI Companies Fix ‘Delusion’ Outputs by Chatbots
Dec 11, 2025 by
CPI
Texas Sues Epic Systems, Accusing Health-Tech Giant of Anticompetitive Data Practices
Dec 11, 2025 by
CPI
Court Affirms Apple Injunction but Trims Limits in Epic Dispute
Dec 11, 2025 by
CPI
Cloud Providers Challenge EU Approval of Broadcom–VMware Deal
Dec 11, 2025 by
CPI
NASCAR, 23XI and Front Row Settle Antitrust Dispute in Confidential Agreement
Dec 11, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Acqui-hiring
Dec 11, 2025 by
CPI
Anticompetitive Effects of Acquihires: Labor and Product Markets
Dec 11, 2025 by
Heski Bar-Isaac, Justin Johnson & Volker Nocke
Acquihires In the Technology Sector: Antitrust Scrutiny Through the Lens of Economics
Dec 11, 2025 by
Juliette Caminade, Rebecca Kirk Fair, Zsolt Udvari & Jeanne Vellard Smith
M&A in the AI Era: Considerations for Acquihiring
Dec 11, 2025 by
Ingrid Vandenborre, Kenneth Schwartz, Christopher Barlow, Page Griffin, Michael Cardella, Stuart Levi, Taylor Votek, Benjamin Salzer, Lisa G. Liu & Liz Kraus
Lock Them Up, or Take No Prisoners? Merger Policy and Acquiring AI Talent: Human Rights and Other Inconvenient Facts
Dec 11, 2025 by
Simon R. Pritchard